Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Total Current Liabilities: 2010-2024

Historic Total Current Liabilities for Ligand Pharmaceuticals (LGND) over the last 15 years, with Dec 2024 value amounting to $37.1 million.

  • Ligand Pharmaceuticals' Total Current Liabilities rose 23.28% to $30.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.5 million, marking a year-over-year increase of 23.28%. This contributed to the annual value of $37.1 million for FY2024, which is 121.14% up from last year.
  • Ligand Pharmaceuticals' Total Current Liabilities amounted to $37.1 million in FY2024, which was up 121.14% from $16.8 million recorded in FY2023.
  • Ligand Pharmaceuticals' Total Current Liabilities' 5-year high stood at $100.1 million during FY2020, with a 5-year trough of $16.8 million in FY2023.
  • For the 3-year period, Ligand Pharmaceuticals' Total Current Liabilities averaged around $50.9 million, with its median value being $37.1 million (2024).
  • In the last 5 years, Ligand Pharmaceuticals' Total Current Liabilities surged by 488.82% in 2020 and then slumped by 83.02% in 2023.
  • Over the past 5 years, Ligand Pharmaceuticals' Total Current Liabilities (Yearly) stood at $100.1 million in 2020, then slumped by 58.38% to $41.7 million in 2021, then soared by 137.15% to $98.8 million in 2022, then crashed by 83.02% to $16.8 million in 2023, then spiked by 121.14% to $37.1 million in 2024.